Global ratings agency Fitch revised
Egypt s outlook to positive from stable on Friday. The agency affirmed Eygpt s rating at B- , citing
reduced external financing risks and stronger. -May 03, 2024 at 05:08 pm EDT
- MarketScreener
By Sruthi Narasimha Chari (Reuters) -The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neurocrine Biosciences' Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on Tu.
Insurance provider Aflac
reported first-quarter profit above analysts estimates on
Wednesday, helped by improved premiums earned in the United
States. Aflac s shares rose 1.42% in.
Dexcom beat Wall Street
expectations for first-quarter profit on Thursday, helped by
strong demand for a new version of its continuous glucose
monitors, but its shares slid 7% after the bell as annual.